The Home Oxygen Transfill System segmentation by application delineates four primary end‑use categories that collectively shape market dynamics. COPD patients represent the largest share, accounting for roughly 45 % of total demand, driven by the chronic nature of the disease and the need for long‑term oxygen therapy at home. Home care facilities contribute about 30 % as institutional operators procure transfill units to support multiple residents, leveraging economies of scale and centralized maintenance. Palliative care settings, encompassing hospice and end‑of‑life services, generate approximately 15 % of volume, reflecting the requirement for reliable, low‑maintenance oxygen delivery in comfort‑focused environments. Finally, post‑surgical recovery accounts for the remaining 10 %, where short‑term oxygen supplementation is prescribed to accelerate convalescence. Each application segment influences the overall market size through distinct purchasing cycles, usage intensities, and regulatory considerations, enabling analysts to attribute revenue streams to specific clinical contexts.